Therapeutic potential of Angelica sinensis in addressing organ fibrosis: A comprehensive review

• Published in: Biomedicine & pharmacotherapy 2024-04, Vol.173, p.116429-116429, Article 116429
• Main Authors: Zhi, Xiaodong, Ren, Chunzhen, Li, Qianrong, Xi, Huaqing, Li, Dong, Chen, Qilin, Lv, Xinfang, Gao, Xiang, Wu, Xue, Wang, Chunling, Jiang, Bing, Mao, Zhongnan, Jiang, Hugang, Liu, Kai, Zhao, Xinke, Li, Yingdong
• Format: Article
• Language: English
• Subjects: Angelica sinensis; Angelica sinensis - chemistry; Hepatic fibrosis; Medicine, Chinese Traditional; Myocardial fibrosis; Myofibroblast; Organ fibrosis; Phytotherapy; Prospective Studies; Pulmonary fibrosis; Pulmonary Fibrosis - drug therapy; Renal fibrosis
• ISSN: 0753-3322; 1950-6007
• DOI: 10.1016/j.biopha.2024.116429

Fibrosis-related diseases (FRD) include conditions like myocardial fibrosis, pulmonary fibrosis, hepatic fibrosis, renal fibrosis, and others. The impact of fibrosis can be severe, causing organ dysfunction, reduced functionality, and even organ failure, leading to significant health issues. Currently, there is a lack of effective modern anti-fibrosis drugs in clinical practice. However, Chinese medicine has a certain beneficial effect on the treatment of such diseases. Angelica sinensis, with its considerable medicinal value, has garnered attention for its anti-fibrosis properties in recent investigations. In the past few years, there has been a growing number of experimental inquiries into the impact of angelica polysaccharide (ASP), angelica water extract, angelica injection, and angelica compound preparation on fibrosis-associated ailments, piquing the interest of researchers. This paper aims to consolidate recent advances in the study of Angelica sinensis for the treatment of fibrosis-related disorders, offering insights for prospective investigations. Literature retrieval included core electronic databases, including Baidu Literature, CNKI, Google-Scholar, PubMed, and Web of Science. The applied search utilized specified keywords to extract relevant information on the pharmacological and phytochemical attributes of plants. The investigation revealed that Angelica sinensis has the potential to impede the advancement of fibrotic diseases by modulating inflammation, oxidative stress, immune responses, and metabolism. ASP, Angelica sinensis extract, Angelica sinensis injection, and Angelica sinensis compound preparation were extensively examined and discussed. These constituents demonstrated significant anti-fibrosis activity. In essence, this review seeks to gain a profound understanding of the role of Angelica sinensis in treating fiber-related diseases. Organ fibrosis manifests in nearly all tissues and organs, posing a critical challenge to global public health due to its widespread occurrence, challenging early diagnosis, and unfavorable prognosis. Despite its prevalence, therapeutic options are limited, and their efficacy is constrained. Over the past few years, numerous studies have explored the protective effects of traditional Chinese medicine on organ fibrosis, with Angelica sinensis standing out as a multifunctional natural remedy. This paper provides a review of organ fibrosis pathogenesis and summarizes the recent two decades’ progress in tr